FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1582130462> ?p ?o ?g. }

• W1582130462 endingPage "131" @default.
• W1582130462 startingPage "123" @default.
• W1582130462 abstract "Abstract In a prospective multicenter study, 368 acute lymphoblastic leukemia (ALL) patients aged 15 to 65 years were treated with an intensified induction and reinduction regimen; 272 (73.9%) achieved complete remission (CR). The median remission duration (MRD) is 24.3 months, and the probability of being in continuous CR (CCR) at greater than 5 years is .37. The median survival for all 368 patients is 27.5 months, and the probability of being alive at 5 years is .39. For the 272 patients in remission the median survival is 58.4 months, and the probability of being alive at 5 years is .49. A lower CR rate was seen for patients with bleeding at diagnosis or with splenomegaly/hepatosplenomegaly. The prognostic factors unfavorable for remission duration were time to CR greater than 4 weeks v less than 4 weeks (P = .0002), age greater than 35 years v less than 35 years (P = .0008), leukocyte count greater than 30,000/microL v less than 30,000/microL (P = .0112), and null ALL v common ALL (c-ALL)/T cell ALL (T-ALL) (P = .05). The remission duration correlated strongly (P = .0001) with the number of these independent prognostic factors. In patients with none of these adverse factors the MRD has not yet been reached, with one adverse factor the MRD is 21.9 months, and with two or three adverse factors the MRD is only 9.6 months. For the immunologic subtype T-ALL, the probability of being in CCR at greater than 5 years is .55; for c-ALL, .34; and for null ALL, .24. According to these results, patients were stratified into a low- risk group with a CCR rate of .62 and a high-risk group with a CCR rate of .28, with the latter now allocated to either further chemotherapy or bone marrow transplantation in first remission." @default.
• W1582130462 created "2016-06-24" @default.
• W1582130462 creator A5005594026 @default.
• W1582130462 creator A5013231760 @default.
• W1582130462 creator A5021523215 @default.
• W1582130462 creator A5028673634 @default.
• W1582130462 creator A5042935151 @default.
• W1582130462 creator A5058443791 @default.
• W1582130462 creator A5062688084 @default.
• W1582130462 creator A5066213019 @default.
• W1582130462 creator A5073667628 @default.
• W1582130462 creator A5091537377 @default.
• W1582130462 date "1988-01-01" @default.
• W1582130462 modified "2023-10-16" @default.
• W1582130462 title "Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults" @default.
• W1582130462 cites W1491154431 @default.
• W1582130462 cites W1519771525 @default.
• W1582130462 cites W1537060962 @default.
• W1582130462 cites W1580788756 @default.
• W1582130462 cites W158940948 @default.
• W1582130462 cites W1979300931 @default.
• W1582130462 cites W1983233287 @default.
• W1582130462 cites W1989937920 @default.
• W1582130462 cites W1992636526 @default.
• W1582130462 cites W1996462672 @default.
• W1582130462 cites W2014249858 @default.
• W1582130462 cites W2018413926 @default.
• W1582130462 cites W2023024337 @default.
• W1582130462 cites W2034309619 @default.
• W1582130462 cites W2044988940 @default.
• W1582130462 cites W2071249703 @default.
• W1582130462 cites W2092559616 @default.
• W1582130462 cites W2139984188 @default.
• W1582130462 cites W2163251241 @default.
• W1582130462 cites W2218795077 @default.
• W1582130462 cites W2237674527 @default.
• W1582130462 cites W2288724096 @default.
• W1582130462 cites W2336990540 @default.
• W1582130462 cites W2338132376 @default.
• W1582130462 cites W2409897565 @default.
• W1582130462 cites W2415051142 @default.
• W1582130462 cites W2418353167 @default.
• W1582130462 cites W2432390062 @default.
• W1582130462 cites W2439672092 @default.
• W1582130462 cites W2467006010 @default.
• W1582130462 cites W2467334241 @default.
• W1582130462 cites W629661748 @default.
• W1582130462 cites W76703940 @default.
• W1582130462 doi "https://doi.org/10.1182/blood.v71.1.123.123" @default.
• W1582130462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3422030" @default.
• W1582130462 hasPublicationYear "1988" @default.
• W1582130462 type Work @default.
• W1582130462 sameAs 1582130462 @default.
• W1582130462 citedByCount "575" @default.
• W1582130462 countsByYear W15821304622012 @default.
• W1582130462 countsByYear W15821304622013 @default.
• W1582130462 countsByYear W15821304622014 @default.
• W1582130462 countsByYear W15821304622015 @default.
• W1582130462 countsByYear W15821304622016 @default.
• W1582130462 countsByYear W15821304622017 @default.
• W1582130462 countsByYear W15821304622018 @default.
• W1582130462 countsByYear W15821304622019 @default.
• W1582130462 countsByYear W15821304622020 @default.
• W1582130462 countsByYear W15821304622021 @default.
• W1582130462 countsByYear W15821304622022 @default.
• W1582130462 countsByYear W15821304622023 @default.
• W1582130462 crossrefType "journal-article" @default.
• W1582130462 hasAuthorship W1582130462A5005594026 @default.
• W1582130462 hasAuthorship W1582130462A5013231760 @default.
• W1582130462 hasAuthorship W1582130462A5021523215 @default.
• W1582130462 hasAuthorship W1582130462A5028673634 @default.
• W1582130462 hasAuthorship W1582130462A5042935151 @default.
• W1582130462 hasAuthorship W1582130462A5058443791 @default.
• W1582130462 hasAuthorship W1582130462A5062688084 @default.
• W1582130462 hasAuthorship W1582130462A5066213019 @default.
• W1582130462 hasAuthorship W1582130462A5073667628 @default.
• W1582130462 hasAuthorship W1582130462A5091537377 @default.
• W1582130462 hasBestOaLocation W15821304621 @default.
• W1582130462 hasConcept C126322002 @default.
• W1582130462 hasConcept C141071460 @default.
• W1582130462 hasConcept C188816634 @default.
• W1582130462 hasConcept C197934379 @default.
• W1582130462 hasConcept C2776694085 @default.
• W1582130462 hasConcept C2778336483 @default.
• W1582130462 hasConcept C2779134260 @default.
• W1582130462 hasConcept C2779440204 @default.
• W1582130462 hasConcept C2781413609 @default.
• W1582130462 hasConcept C71924100 @default.
• W1582130462 hasConcept C90924648 @default.
• W1582130462 hasConceptScore W1582130462C126322002 @default.
• W1582130462 hasConceptScore W1582130462C141071460 @default.
• W1582130462 hasConceptScore W1582130462C188816634 @default.
• W1582130462 hasConceptScore W1582130462C197934379 @default.
• W1582130462 hasConceptScore W1582130462C2776694085 @default.
• W1582130462 hasConceptScore W1582130462C2778336483 @default.
• W1582130462 hasConceptScore W1582130462C2779134260 @default.
• W1582130462 hasConceptScore W1582130462C2779440204 @default.
• W1582130462 hasConceptScore W1582130462C2781413609 @default.

• next